Skip to content
10-Q

Quarterly Report

ARCTURUS THERAPEUTICS HOLDINGS INC. ARCT

0000950170-25-106560

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 27.15M sh
Shares Diluted Q2 2025 · Jun 30, 2025 27.13M sh
Shares Diluted Q2 2025 · Jun 30, 2025 27.12M sh
Shares Diluted Q2 2025 · Jun 30, 2024 26.97M sh
Shares Diluted Q2 2025 · Jun 30, 2024 26.92M sh
Capex Q2 2025 · Jun 30, 2025 $137K
Capex Q2 2025 · Jun 30, 2024 $568K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$40.89M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$35.7M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $196.47M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $237.03M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $260.33M
Stockholders Equity Q2 2025 · Jun 30, 2025 $231.05M
Stockholders Equity Q2 2025 · Mar 31, 2025 $233.76M
Stockholders Equity Q2 2025 · Dec 31, 2024 $240.98M
Stockholders Equity Q2 2025 · Jun 30, 2024 $258.58M
Stockholders Equity Q2 2025 · Mar 31, 2024 $263.97M
Stockholders Equity Q2 2025 · Dec 31, 2023 $278.51M
Current Liabilities Q2 2025 · Jun 30, 2025 $46.52M
Current Liabilities Q2 2025 · Dec 31, 2024 $65.49M
Total Liabilities Q2 2025 · Jun 30, 2025 $78.22M
Total Liabilities Q2 2025 · Dec 31, 2024 $103.09M
Current Assets Q2 2025 · Jun 30, 2025 $274.5M
Current Assets Q2 2025 · Dec 31, 2024 $305.98M
Total Assets Q2 2025 · Jun 30, 2025 $309.27M
Total Assets Q2 2025 · Dec 31, 2024 $344.07M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.34
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.86
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.64
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.64
Eps Basic Q2 2025 · Jun 30, 2025 −$0.34
Eps Basic Q2 2025 · Jun 30, 2025 −$0.86
Eps Basic Q2 2025 · Jun 30, 2024 −$0.64
Eps Basic Q2 2025 · Jun 30, 2024 −$1.64
Sga Expense Q2 2025 · Jun 30, 2025 $10.34M
Sga Expense Q2 2025 · Jun 30, 2025 $21.65M
Sga Expense Q2 2025 · Jun 30, 2024 $12.32M
Sga Expense Q2 2025 · Jun 30, 2024 $27.17M
Rd Expense Q2 2025 · Jun 30, 2025 $29.58M
Rd Expense Q2 2025 · Jun 30, 2025 $64.47M
Rd Expense Q2 2025 · Jun 30, 2024 $58.67M
Rd Expense Q2 2025 · Jun 30, 2024 $112.24M
Net Income Q2 2025 · Jun 30, 2025 −$9.18M
Net Income Q2 2025 · Jun 30, 2025 −$23.26M
Net Income Q2 2025 · Jun 30, 2024 −$17.22M
Net Income Q2 2025 · Jun 30, 2024 −$44.03M
Net Income Q2 2025 · Mar 31, 2024 −$26.82M
Operating Income Q2 2025 · Jun 30, 2025 −$11.62M
Operating Income Q2 2025 · Jun 30, 2025 −$28.44M
Operating Income Q2 2025 · Jun 30, 2024 −$21.13M
Operating Income Q2 2025 · Jun 30, 2024 −$51.54M
Revenue Q2 2025 · Jun 30, 2025 $28.3M
Revenue Q2 2025 · Jun 30, 2025 $57.68M
Revenue Q2 2025 · Jun 30, 2024 $49.86M
Revenue Q2 2025 · Jun 30, 2024 $87.87M